Bristol Myers Squibb
Princeton, New Jersey, United States · Biopharma, Biotechnology, Health Care
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
Key facts
- Headquarters
- Princeton, New Jersey, United States
- Employees
- 33,000
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Public (BMY)
- Website
- www.bms.com
- Company page
Recent activity at Bristol Myers Squibb
- : Bristol Myers Squibb Appoints Cristian Massacesi as Head of R&D
- : Bristol Myers Squibb Ends Partnership with Cellares Over CAR-T Therapy Manufacturing Challenges. (date Fundz recorded it)
- : Bristol-Myers acquires Medarex for cancer pipeline
- : Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager of Saudi Arabia and Gulf Countries
- : Bristol-Myers Squibb Partners With Anthropic to Enhance Drug Discovery Through AI (date Fundz recorded it)
- : Bristol Myers Squibb partners with Hengrui Pharma for a multi-billion dollar collaboration to develop new drugs. (date Fundz recorded it)
- : Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs.
- : SEC 8-K (7.01): On October 29, 2026, Bristol-Myers Squibb Company disseminated a presentation regarding its financial and operating initiatives as part of its earnings conference call for Q3 2026. This presentation, available on the company's website, includes references to non-GAAP financial information along with reconciliations to GAAP measures. The material is intended to provide insights into the company's financial performance and outlook, and it is accompanied by an earnings press release, also dated October 29, 2026. The filing indicates the company's ability to modify access to the presentation at its discretion, impacting how stakeholders can review the company’s financial health in the short term.
- : SEC 8-K (7.01): On July 30, 2026, Bristol-Myers Squibb Company provided a Regulation FD Disclosure by posting a presentation on its website regarding financial and operating initiatives as part of its conference call announcing second quarter 2026 financial results. The presentation, referred to as the 'Bristol Myers Presentation', includes non-GAAP financial information with reconciliations to GAAP measures available in the Earnings Press Release. This indicates a strategic communication of the company's financial performance and outlook to investors and stakeholders. Additionally, the Company retains the right to remove the presentation from its website at any time.
- : SEC 8-K (7.01): On April 30, 2026, Bristol-Myers Squibb Company posted a presentation regarding financial and operational initiatives on its website. This presentation was made available during a conference call announcing their financial results for the first quarter of 2026. The materials include non-GAAP financial information along with reconciliations to GAAP measures. The presentation aims to inform stakeholders about the company's performance and strategies, reinforcing transparency as required by Regulation FD.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Alejandra Allard, HR Director Mexico, Colombia & Peru
- Amanda Poole, Chief People Officer
- Cristian Massacesi, Chief Medical Officer
- Mayada Al-Ahmad, Manager
- Sandra Zeng, Chief Medical Officer
- Jon Glines, Specialty Sales Representative
- Cosimo Vavallo, Product Specialist-Immuno Oncology
- Meg Anderson, Vice President, Neurology and Gi Immunology Sales & Marketing
- Carole Bertola, Director Global Strategic Sourcing & Procurement
- Vanessa E Hasle, Principal Scientist
- Raquel Pinacho Castro, Marketing Strategist Hematology
- Jacob Zalaznick, Principal Scientist
Verified email and direct lines for Bristol Myers Squibb’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Bristol Myers Squibb files 27 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Bristol Myers Squibb in the news
- Technologies - Bristol Myers Squibb (Jun 16, 2026)
- Bristol Myers Squibb employees cycle across four continents to advance cancer research - Bristol Myers Squibb (Jun 30, 2026)
- U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse - Bristol Myers Squibb (Aug 13, 2026)
- Greg Meyers - Bristol Myers Squibb (Jun 16, 2026)
- Chris Boerner, Board Chair and Chief Executive Officer - Bristol Myers Squibb (Jun 16, 2026)
- A bold blueprint for transforming outcomes in lupus - Bristol Myers Squibb (Dec 03, 2025)
- Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas - Bristol Myers Squibb (Aug 10, 2026)
- Early progress on accelerating drug development with Claude - Anthropic (Oct 27, 2026)
Companies similar to Bristol Myers Squibb
- AbbVie Inc. · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- Jazz Pharmaceuticals plc · Biopharma, Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- Teva Pharmaceutical Industries Ltd · Biotechnology, Health Care, Manufacturing, Pharmaceutical, Therapeutics
- Eli Lilly and Company · Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical
- Genentech · Biotechnology, Health Care, Manufacturing, Medical, Therapeutics
About Bristol Myers Squibb: questions and answers
What does Bristol Myers Squibb do?
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
Where is Bristol Myers Squibb headquartered?
Bristol Myers Squibb is headquartered in Princeton, New Jersey, United States.
How many employees does Bristol Myers Squibb have?
Bristol Myers Squibb has about 33,000 employees.
Who leads Bristol Myers Squibb?
Meg Anderson is a Vice President, Neurology and Gi Immunology Sales & Marketing at Bristol Myers Squibb.
What is the latest news on Bristol Myers Squibb?
On Nov 15, 2026, Bristol Myers Squibb Appoints Cristian Massacesi as Head of R&D
Is Bristol Myers Squibb a public company?
Yes. Bristol Myers Squibb is publicly traded under the ticker BMY.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy